In general, our research indicated that CAFs-sEV circN4BP2L2 promoted CRC progression by regulating miR-664b-3p/HMGB3/Wnt/β-catenin pathway, which might provide a novel insight into the potential treatment target for CRC. Here, HMGB3 is linked to colorectal carcinoma.